Jacobsen Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$366K Buy
1,011
+12
+1% +$4.11K 0.11% 81
2026
Q1
$351K Sell
999
-1
-0.1% -$356 0.12% 74
2025
Q4
$327K Sell
1,000
-9
-0.9% -$2.85K 0.11% 76
2025
Q3
$285K Sell
1,009
-4
-0.4% -$1.16K 0.1% 84
2025
Q2
$283K Buy
1,013
+161
+19% +$45.6K 0.1% 82
2025
Q1
$265K Buy
852
+58
+7% +$17.1K 0.12% 76
2024
Q4
$207K Sell
794
-12
-1% -$3.56K 0.09% 92
2024
Q3
$260K Buy
806
+8
+1% +$2.62K 0.11% 76
2024
Q2
$249K Buy
798
+29
+4% +$8.52K 0.11% 76
2024
Q1
$219K Buy
769
+2
+0.3% +$585 0.1% 85
2023
Q4
$221K Buy
+767
New +$209K 0.11% 76

Other funds holding AMGN

Jacobsen Capital Management's AMGN Position: Q2 2026 in Review

Jacobsen Capital Management increased its Amgen (AMGN) stake by 1.2% in Q2 2026, buying an estimated $4.11K and bringing the position to 1,011 shares worth $366K. The position accounts for 0.11% of the portfolio, ranked #81.

Jacobsen Capital Management first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Jacobsen Capital Management held 1,011 shares of Amgen worth $366K as of Q2 2026.
  • Jacobsen Capital Management bought 12 Amgen shares in Q2 2026, an estimated $4.11K.
  • Amgen made up 0.11% of Jacobsen Capital Management's portfolio in Q2 2026, its #81 holding.
  • Jacobsen Capital Management first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Jacobsen Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.